Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells-Reference-Cited by-同舟云学术

Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells

Published:2013-02-04 Issue:8 Volume:110 Page:3023-3028
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Hiramoto T.,Ebihara Y.,Mizoguchi Y.,Nakamura K.,Yamaguchi K.,Ueno K.,Nariai N.,Mochizuki S.,Yamamoto S.,Nagasaki M.,Furukawa Y.,Tani K.,Nakauchi H.,Kobayashi M.,Tsuji K.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference27 articles.

1. Clinical implications ofELA2-,HAX1-, and G-CSF-receptor (CSF3R) mutations in severe congenital neutropenia

2. A randomized controlled phase III trial of recombinant human granulocyte colony-stimulating factor (filgrastim) for treatment of severe chronic neutropenia

3. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy

4. Prevalence of mutations inELANE,GFI1,HAX1,SBDS,WASandG6PC3in patients with severe congenital neutropenia

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inherited Bone Marrow Failure Syndromes;Comprehensive Hematology and Stem Cell Research;2024

2. PAM-flexible Cas9-mediated base editing of a hemophilia B mutation in induced pluripotent stem cells;Communications Medicine;2023-04-19

3. Congenital neutropenia: disease models guiding new treatment strategies;Current Opinion in Hematology;2021-11-24

4. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives;Biomolecules;2021-05-07

5. iPSC modeling of stage-specific leukemogenesis reveals BAALC as a key oncogene in severe congenital neutropenia;Cell Stem Cell;2021-05